Saturday, September 3, 2011

Low-dose naltrexone (LDN): Tricking the body to heal itself

ScienceDaily: Latest Science News
Researchers have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN) can suppress cell proliferative-related disorders such as cancer and autoimmune diseases. LDN causes a compensatory increase in an endogenous opioid, the opioid growth factor (OGF, [Met5]-enkephalin), and the OGF receptor (OGFr).
Sent with Reeder
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)